the effects of cyclophosphamide , ketoconazole , aclacinomycin-a , methotrexate , and scheduled methotrexate-5-fluorouracil combination chemotherapy on the transplantable r-3327 prostatic adenocarcinoma in the f1 hybrid male rat .
C0025677
methotrexate
C0280603
methotrexate